Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 80Breast 79Gynecologic 58Genitourinary 52Tumor-Agnostic 48Head & Neck 40Thoracic 30Other hematologic neoplasm 27Lymphoid 25CNS 23Dermatologic 19Sarcoma 13Other 9Plasma cell 8Myeloid 8Endocrine 8Other solid neoplasm 7Classical hematology 7Other neoplasm 3NET 1

Conditions

Neuroendocrine Tumors 1Neoplasms 1

Interventions

lutetium Lu 177 dotatate 6Magnetic Resonance Spectroscopy 3Data Collection 3telotristat ethyl 2surufatinib 2Somatostatin 2Positron-Emission Tomography 2Everolimus 2Drug Therapy 2Biopsy 2lanreotide 1copper dotatate CU-64 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Sorafenib 1Salvage Therapy 1Radionuclide Imaging 1Radiomics 1Radiofrequency Ablation 1Quality of Life 1Plastic Surgery Procedures 1Phlebotomy 1Patient Reported Outcome Measures 1Octreotide 1Molecular Diagnostic Techniques 1Lutetium-177 1Lutetium 1Liver Transplantation 1Laparoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Surveys and Questionnaires × NET × Clear all
NCT07258810 2025-12-02

ETP-NET

Hospices Civils de Lyon

Not yet recruiting
100 enrolled
EndocrineNET

Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡